lymphoma: be on rise

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents cancer
Weight: 0.65
, type
Weight: 0.63
, breast cancer
Weight: 0.60
, blood
Weight: 0.58
, tumor
Weight: 0.58
Siblings skin cancer
Weight: 0.39
, melanoma
Weight: 0.38
, liver cancer
Weight: 0.38
, lung cancer
Weight: 0.38
, prostate cancer
Weight: 0.38

Related properties

Property Similarity
be on rise 1.00

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.39
Rule weight: 0.66
Evidence weight: 0.58
Similarity weight: 1.00
Evidence: 0.05
Plausible(breast cancer, be on rise)
Evidence: 0.44
¬ Typical(lymphoma, be on rise)

Plausibility inheritance from parent to child

0.09
Rule weight: 0.09
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.05
¬ Plausible(breast cancer, be on rise)

Remarkability exclusitivity betweem a parent and a child

0.55
Rule weight: 0.58
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.10
¬ Remarkable(breast cancer, be on rise)

Remarkability exclusitivity between siblings

0.12
Rule weight: 0.13
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.16
¬ Remarkable(prostate cancer, be on rise)
0.12
Rule weight: 0.13
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.18
¬ Remarkable(melanoma, be on rise)
0.12
Rule weight: 0.13
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.20
¬ Remarkable(lung cancer, be on rise)
0.12
Rule weight: 0.13
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.22
¬ Remarkable(liver cancer, be on rise)
0.12
Rule weight: 0.13
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.24
¬ Remarkable(skin cancer, be on rise)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.05
Plausible(breast cancer, be on rise)
Evidence: 0.36
Remarkable(lymphoma, be on rise)
Evidence: 0.33
¬ Plausible(lymphoma, be on rise)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.24
Remarkable(skin cancer, be on rise)
Evidence: 0.09
¬ Plausible(skin cancer, be on rise)
0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.22
Remarkable(liver cancer, be on rise)
Evidence: 0.09
¬ Plausible(liver cancer, be on rise)
0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.16
Remarkable(prostate cancer, be on rise)
Evidence: 0.09
¬ Plausible(prostate cancer, be on rise)
0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.20
Remarkable(lung cancer, be on rise)
Evidence: 0.10
¬ Plausible(lung cancer, be on rise)
0.52
Rule weight: 0.60
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.18
Remarkable(melanoma, be on rise)
Evidence: 0.24
¬ Plausible(melanoma, be on rise)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.30
¬ Salient(lymphoma, be on rise)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.30
Salient(lymphoma, be on rise)
Evidence: 0.44
¬ Typical(lymphoma, be on rise)
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)

Typical implies Plausible

0.34
Rule weight: 0.48
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.33
Plausible(lymphoma, be on rise)
Evidence: 0.44
¬ Typical(lymphoma, be on rise)

Typicality and Rermarkability incompatibility between a parent and a child

0.47
Rule weight: 0.51
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.21
¬ Typical(breast cancer, be on rise)

Typicality and Rermarkability incompatibility between siblings

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.18
¬ Typical(skin cancer, be on rise)
0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.20
¬ Typical(liver cancer, be on rise)
0.12
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.25
¬ Typical(lung cancer, be on rise)
0.12
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.26
¬ Typical(prostate cancer, be on rise)
0.11
Rule weight: 0.14
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(lymphoma, be on rise)
Evidence: 0.49
¬ Typical(melanoma, be on rise)

Typicality inheritance from parent to child

0.43
Rule weight: 0.48
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.44
Typical(lymphoma, be on rise)
Evidence: 0.21
¬ Typical(breast cancer, be on rise)